Switch Bioworks – Weekly Recap

Switch Bioworks, a biotechnology company developing biologically powered, low-cost sustainable fertilizer solutions, reported a series of leadership, infrastructure, and scientific updates that collectively indicate a move from early-stage research toward scaled R&D and commercialization readiness. This weekly recap summarizes the key developments shaping the company’s current trajectory.

The company expanded its executive leadership team with the appointment of Steve del Cardayre as Chief Technology Officer, Brett Boghigian as Chief Business Officer, and climate-tech veteran Kaitlyn Qin as Chief Financial Officer. These additions bring deep experience in industrial and agricultural biotechnology, commercialization strategy, and financial and capital planning, strengthening Switch Bioworks’ capacity to manage product development, regulatory pathways, and go-to-market execution for its sustainable fertilizer platform. The organization also added Senior Research Associate Jose Zaragoza to bolster R&D capabilities and appointed Liz Freeman Rosenzweig as Senior Counsel to oversee intellectual property, regulatory, legal, and government affairs.

Operationally, Switch Bioworks relocated to a new headquarters in San Carlos, California, tripling its R&D footprint and consolidating fermentation, plant growth rooms, laboratories, and offices into a single facility. This expanded infrastructure is designed to increase experimental throughput, support larger-scale trials, and enhance the company’s product development engine as it advances its biofertilizer technologies.

On the scientific and strategic front, the company’s leadership presented at the Microbiome AgBio Tech Summit and the European Nitrogen Fixation Conference, highlighting work on microbial consortia and engineered genetic circuits aimed at cost-effective, climate-focused biofertilizers. Advisory strength was reinforced by agrifood industry veteran Eric Bartels joining as an advisor and by the election of board member Doug Cameron and founding advisor Jennifer Cochran to the National Academy of Engineering, developments that enhance Switch Bioworks’ scientific credibility and commercialization guidance.

Internally, Switch Bioworks held an annual off-site focused on communication, strategy alignment, and team building, alongside continued hiring efforts that point to ongoing headcount growth and investment in organizational capacity. While no financial metrics, revenue figures, or specific commercialization timelines were disclosed, the week’s updates collectively suggest a company strengthening its leadership, infrastructure, and technical foundations to support future scale-up, field validation, and market engagement in the ag-biologicals and climate-tech sectors. Overall, the week marked a notable consolidation of capabilities and positioning for Switch Bioworks as it advances its sustainable nitrogen solutions toward broader deployment.